Drafted in partnership with the O’Neill Institute for National and Global Health Law at Georgetown University, the purpose of the this model legislation is to: (1) promote the use of all U.S. Food and Drug Administration-approved medication for addiction treatment options in correctional settings; (2) ensure that all incarcerated individuals with a substance use disorder are provided access to medication for addiction treatment while incarcerated, are treated as individual patients, and have individualized treatment plans reflecting their clinical needs and not a one-size-fits-all approach; and (3) ensure that, upon release from a correctional setting, individuals receiving medication for addiction treatment are provided with a connection in the community for continued care, including a prescription for the medication for addiction treatment and the necessary contacts and tools to continue their treatment.

Read the Model Access to Medication for Addiction Treatment in Correctional Settings Act.

Please note that this is an update of a model act that was first released by LAPPA in 2020.